أخبار السوق اليوم — عناوين الأسهم والعملات الرقمية المنتقاة بالذكاء الاصطناعي

New homeowners pay 3 times more property tax than their neighbors in some places. Here’s what they can do about it.

The “newcomer tax” is steep — and spreading.

3 questions to ask before raiding your 401(k) for a hardship withdrawal

Money coaches tell you how to move past the stigma and decide if tapping your retirement fund is rational or …

Japanese FX intervention wipes out yen’s Iran war losses — but fails to eliminate market concerns

“FX intervention will only get them so far,” one strategist said after the yen surged.

The Tech Download: Chip stocks surge in ‘historic’ month as investors’ AI buildout concerns ease

March saw many chip stocks drop amid concerns over the AI buildout, but their fortunes have reversed in April.

Here’s why software stocks are finally priced for a comeback and this veteran strategist is buying

Fundstrat’s head of research Tom Lee says investors are underestimating how strong software companies will rise to the AI challenge.

Twilio’s stock is soaring. The company says it’s because of ‘unprecedented demand’ for one AI function.

The software company’s stock rose 20% in a boost to the sector that has been dragged down over concerns about …

Apollo Sports Capital and Tom Dundon make landmark $225 million investment in pickleball

The fresh funds bring the total investment in Pickleball Inc. to $315 million, as investors continue to look at emerging …

Berkshire’s stock has suffered in a post-Buffett world. Why that’s actually a good thing.

New CEO Greg Abel has the biggest investment shoes to fill — but he also had the best coach, which …

Berkshire shares struggle into annual meeting. Can Abel rekindle enthusiasm without Buffett center stage?

For the first time, the 95-year-old Buffett won't be the central figure on stage, marking a new era for one …

Exxon Mobil and Chevron earnings fall as Iran war disrupts oil shipments

Oil prices were depressed during the first two months of the year, but suddenly spiked after the U.S. and Israel …

AstraZeneca stock falls after FDA panel votes against new cancer drug

The advisory panel wasn't convinced that a clinical trial proved that early switching to camizestrant improved long-term survival rates.